Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
LivaNova PLC (LIVN)
NASDAQ:LIVN
Holding LIVN?
Track your performance easily
LIVN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$42.75 - $64.48
Previous Close$51
Volume565.45K
Average Volume (3M)691.55K
Market Cap
$2.77B
Enterprise Value$3.11B
Total Cash (Recent Filing)$329.24M
Total Debt (Recent Filing)$668.69M
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Oct 30, 2024EPS Estimate
$0.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding54,297,960
10 Day Avg. Volume461,703
30 Day Avg. Volume691,548
Standard Deviation0.11
R-Squared0.23
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.23
Price to Sales (P/S)2.19
Price to Cash Flow (P/CF)15.20
P/FCF Ratio21.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.57
Enterprise Value/Gross Profit4.03
Enterprise Value/Ebitda136.71
Forecast
1Y Price Target
$69.80Price Target Upside36.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
LivaNova News
PremiumCompany Announcements
LivaNova Announces CHRO Hebbelinck’s Planned Departure and Benefits
Bulls Say, Bears Say
Bulls Say
ReimbursementA CMS Advisory Panel on Hospital Outpatient Payment evaluated a potential increase US VNS reimbursement, by about +40% that is believed to have received a favorable 'vote.'
Revenue GrowthUpgrading LIVN after management quantified growth levers in FY25/beyond at the Baird Conference that point to clear revenue upside over the next several years.
Top-line GrowthBetter top-line growth should translate to LDD EPS growth in FY25-26, above the MSD growth even when accounting for the impact from a potential SNIA payout.
Bears Say
EarningsLIVN still will contend with an EPS headwind from the pending SNIA payout, representing potential neutral-to-downside risk to out-year CNS EPS numbers.
Legal IssuesLIVN still has to contend with Italian litigation overhangs.
ReimbursementLIVN believes that the current reimbursement system for VNS is insufficient for incentivizing hospital systems to pursue the procedure.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LIVN FAQ
What was LivaNova PLC’s price range in the past 12 months?
LivaNova PLC lowest stock price was $42.75 and its highest was $64.47 in the past 12 months.
What is LivaNova PLC’s market cap?
Currently, no data Available
When is LivaNova PLC’s upcoming earnings report date?
LivaNova PLC’s upcoming earnings report date is Oct 30, 2024 which is in 40 days.
How were LivaNova PLC’s earnings last quarter?
LivaNova PLC released its earnings results on Jul 31, 2024. The company reported $0.93 earnings per share for the quarter, beating the consensus estimate of $0.783 by $0.147.
Is LivaNova PLC overvalued?
According to Wall Street analysts LivaNova PLC’s price is currently Undervalued.
Does LivaNova PLC pay dividends?
LivaNova PLC does not currently pay dividends.
What is LivaNova PLC’s EPS estimate?
LivaNova PLC’s EPS estimate is $0.71.
How many shares outstanding does LivaNova PLC have?
LivaNova PLC has 54,297,960 shares outstanding.
What happened to LivaNova PLC’s price movement after its last earnings report?
LivaNova PLC reported an EPS of $0.93 in its last earnings report, beating expectations of $0.783. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of LivaNova PLC?
Among the largest hedge funds holding LivaNova PLC’s share is PRIMECAP Management Co. It holds LivaNova PLC’s shares valued at 328M.
---
LivaNova Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$69.80 (36.68% Upside)
$69.80 (36.68% Upside)
Blogger Sentiment
Neutral
LIVN Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 552.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $69.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.76%
12-Months-Change
Fundamentals
Return on Equity
-1.34%
Trailing 12-Months
Asset Growth
4.77%
Trailing 12-Months
Company Description
LivaNova PLC
LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular, Neuromodulation, and Others. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The Other segment consists of company's shared service expenses for finance, legal, human resources, information technology, and new ventures. Its products include VNS therapy system. oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, and cannulae. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.
---
LIVN Company Deck
---
LIVN Earnings Call
Q2 2024
0:00 / 0:00
---
LIVN Stock 12 Month Forecast
Average Price Target
$69.80
▲(36.68% Upside)
Technical Analysis
Best Analysts Covering LIVN
1 Year
1 Year Success Rate
9/21 ratings generated profit
1 Year Average Return
-5.58%
reiterated a buy rating 2 months ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -5.58% per trade.
---